Skip to content

The treatment of Acne Vulgaris

Comparison of theraputic effects of Tea Tree Oil nanoemulsion gel containing adapalene with commercial form of adapalene gel for the treatment of acne vulgaris

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015090223864N1
Enrollment
160
Registered
2015-10-19
Start date
2016-05-01
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acne vulgaris. acne vulgaris

Interventions

Intervention 1: Topical tea tree oil nanoemulsion loaded 0.1% adapalene gell, one times daily on the clean skin for 3 months. Intervention 2: Topical adapalene gell 0.1%, one times daily on the clean
Treatment - Drugs
Topical tea tree oil nanoemulsion loaded 0.1% adapalene gell, one times daily on the clean skin for 3 months
Topical adapalene gell 0.1%, one times daily on the clean skin for 3 months

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Presence of mild to moderate Acne Vulgaris (up to 10 comedons, papular and/or pustular lesions). Exclusion criteria: pregnant and lactating women, children younger than 15 years old, severe cases of acne (existence of nodules and cysts), receiving anti acne during two weeks prior to study, taking acne creating drugs such as oral or local steroids, spirnolactone, finasteride. Patient with diabetes mellitus, endocrine disorder.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Inflammatory and noninflammatory lesions. Timepoint: Baseline and after 4,8, and 12 weeks. Method of measurement: counting lesions using manual lens.

Secondary

MeasureTime frame
Side effect. Timepoint: Baseline and after 4, 8, and 12 weeks. Method of measurement: case report form.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactRoqiye Najafi-Taher

Tehran University of Medical Sciences

r-najafitaher@razi.tums.ac.ir+98 21 8899 1118

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026